| Literature DB >> 33692361 |
Marta Prieto1, Alessandra Folci1, Gwénola Poupon1, Sara Schiavi2, Valeria Buzzelli2, Marie Pronot1, Urielle François3, Paula Pousinha1, Norma Lattuada4, Sophie Abelanet1, Sara Castagnola1, Magda Chafai1, Anouar Khayachi1, Carole Gwizdek1, Frédéric Brau1, Emmanuel Deval1, Maura Francolini4, Barbara Bardoni5, Yann Humeau3, Viviana Trezza2, Stéphane Martin6.
Abstract
Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability and the best-described monogenic cause of autism. CGG-repeat expansion in the FMR1 gene leads to FMR1 silencing, loss-of-expression of the Fragile X Mental Retardation Protein (FMRP), and is a common cause of FXS. Missense mutations in the FMR1 gene were also identified in FXS patients, including the recurrent FMRP-R138Q mutation. To investigate the mechanisms underlying FXS caused by this mutation, we generated a knock-in mouse model (Fmr1R138Q) expressing the FMRP-R138Q protein. We demonstrate that, in the hippocampus of the Fmr1R138Q mice, neurons show an increased spine density associated with synaptic ultrastructural defects and increased AMPA receptor-surface expression. Combining biochemical assays, high-resolution imaging, electrophysiological recordings, and behavioural testing, we also show that the R138Q mutation results in impaired hippocampal long-term potentiation and socio-cognitive deficits in mice. These findings reveal the functional impact of the FMRP-R138Q mutation in a mouse model of FXS.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33692361 PMCID: PMC7946954 DOI: 10.1038/s41467-021-21820-1
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919